MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Diabetes (Glucometers, Glucose Monitoring, Continuous Glucose Monitoring [CGM] Companies)
Hagar_GWave
Attachments
www.hagartech
Parents
*Architects: Diabetes (Glucometers, Glucose Monitoring, Continuous Glucose Monitoring [CGM] Companies)
*Industry: Israel
2021: Cancer treatments lead latest FDA breakthrough device designations
FDA _ Breakthrough Devices Program
Children
2021: HAGAR Secures $11.7M Series B Funding to Advance Non-Invasive Blood Glucose Monitoring Technology
GWave First Generation is a third of the size of a smartphone, and GWave Second Generation, currently in development, will be a sensor built into a comfortable watch the size of a smartwatch that sends glucose readings to the user via a smartphone app that can easily be shared with their healthcare provider.
GWave uses radio frequency waves to continuously measure blood glucose levels
HAGAR N.I.G. (Noninvasive Glucose monitoring) is the developer of GWave, the world's first non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood continuously.
Tel Aviv, Israel